Aratana Therapeutics, Inc.
PETX
PETX was delisted on the 17th of July, 2019.
87 hedge funds and large institutions have $510M invested in Aratana Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 20 reducing their positions, and 8 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
88% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 8
85% more capital invested
Capital invested by funds: $276M → $510M (+$234M)
80% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 20
6% more funds holding
Funds holding: 82 → 87 (+5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCI
Columbus Circle Investors
|
+$6.69M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.6M |
| 3 |
Lazard Asset Management
New York
|
+$6.55M |
| 4 |
VAM
Visium Asset Management
New York
|
+$2.74M |
| 5 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
+$2.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$5.56M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.43M |
| 3 |
JP Morgan Chase
New York
|
-$3.15M |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$2.72M |
| 5 |
Barclays
London,
United Kingdom
|
-$2.5M |
PETX Hedge Fund Activity: Q4 2014 in Review
87 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics, Inc. (PETX) for Q4 2014, worth a combined $510M — up 85% from $276M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new PETX positions and 8 closed out — a net gain of 7 holders — while 36 added to existing stakes and 20 trimmed.
The largest buyer was Columbus Circle Investors, opening a new position worth an estimated $6.69M. The largest seller was Highland Capital Management (Texas), cutting an estimated $5.56M.
- 87 institutional investors held Aratana Therapeutics, Inc. (PETX) as of Q4 2014, up from 82 in Q3 2014.
- Funds reported $510M of Aratana Therapeutics, Inc. stock for Q4 2014, up 85% quarter-over-quarter.
- 15 funds opened new Aratana Therapeutics, Inc. positions in Q4 2014 and 8 closed out, a net change of +7 holders.
- The largest Aratana Therapeutics, Inc. buyer in Q4 2014 was Columbus Circle Investors, an estimated $6.69M added.
- The largest Aratana Therapeutics, Inc. seller in Q4 2014 was Highland Capital Management (Texas), an estimated $5.56M sold.
Based on aggregated 13F filings for Q4 2014.